NEW DELHI: Move over Ethereum and Dogecoin. The names that interest India these days are Cytiva, Sartorius, Corning, Tosoh and Therma Fisher. No crypto currency stars here. All of these are specialty manufacturers of vaccine components. India wants them to open their doors wide for our manufacturers to be able to rollout Covid vaccines for India and the world.
India is the world’s largest vaccine manufacturer, but the shortage it is facing currently says as much about poor governance as it does about the complexities of global supply chains and their increasing interplay with geopolitics and diplomacy. We’re not only in a race between variants and vaccines. At stake is India’s, and to an extent, US’ partnership in a post-Covid world, the future of the Quad, and even India’s global equity as a fair and responsible global player.
The 2-billion Vaccine Question: How realistic are estimates and what s the current status?
SECTIONS
Share
Synopsis
The Centre’s plan for 2 billion doses of Covid-19 vaccines by year-end depends on a massive ramp-up of production as well as flawless trials, approval and manufacturing of five new vaccines. How realistic are the estimates? In what stages are the new vaccines now?
AP
Amid a shortage of Covid-19 vaccines, which has seen many states suspend inoculation sessions, the Centre on May 13 announced that 2 billion doses would be available by the end of the year. This would be a significant leap from the approximately 80 million doses a month currently available.
E-Mail
IMAGE: Percent of children up-to-date with recommended childhood vaccine by age group - Texas, ImmTrac2, May 2010 to May 2020 view more
Credit: Texas A&M University
Despite expert recommendations that children continue to get regularly scheduled vaccines during the pandemic, vaccination rates have decreased in several states.
A new study by researchers from the Texas A&M University School of Public Health and several other research institutions looked at childhood immunization rates in Texas to see what effect the COVID-19 pandemic may have had on childhood immunizations in 2020. In the study, led by public health doctoral student Tasmiah Nuzhath and published in the journal
Despite expert recommendations that children continue to get regularly scheduled vaccines during the COVID-19 pandemic, rates of vaccinations decreased in several states.
Researchers looked at childhood immunization rates in Texas to see what effect the COVID-19 pandemic may have had on childhood immunizations in 2020, using data from a statewide immunization registry to determine how immunization rates changed over a 10-year period for children at four age milestones: 1 month, 5 months, 16 months, and 24 months.
The researchers, led by Tasmiah Nuzhath, a public health doctoral student at Texas A&M University, also analyzed county-level data from 2019 and 2020 to compare rural and urban locations.
Apart from Serum, Bharat Biotech, these 5 vaccine makers are India s hope against Covid-19
The current vaccine makers, Serum Institute and Bharat Biotech, alone won t be able to meet the demand. There are other players too in vaccine production, and they should be able to cater to the demand in the months ahead
Manoj Sharma | May 17, 2021 | Updated 11:19 IST
The government has said India will produce a total of 126 crore vaccines between August-December
A crucial part of India s fight against second Covid-19 wave is vaccination. The country has an uphill task to inoculate about 850 million (85 crore) people over the age of 18. It means India will require 1.7 billion vaccines to inoculate the entire lot under the current phase 3. The government has said India will produce a total of 126 crore vaccines between August-December. Over 35.6 crore doses have been either procured or are in the process of procurement. However, the current vaccine makers Serum Institute - the biggest in t